Antidepressant Induced Hyponatremia: Does It Increase The Risk of Neuroleptic Malignant Syndrome in Elderly Patient?

Nöroleptik Malign Sendrom (NMS) nadir görülen hayatı tehdit eden antipsikotik ilaçlara bağlı gelişen idiosinkratik reaksiyondur. Yaşlı hastalarda hiponatremi sıklıkla görülür ve nöroleptik malign sendrom ile de ilişkilidir. Bu olgu sunumunda bir erkek hastada hiponatremi zemininde antipsikotik doz artırımına ikincil gelişen NMS sunulmuştu

Antidepresanla tetiklenen hiponatremi yaşlı hastalarda Malign Nöroleptik Sendrom riskini arttırır mı?

PDF

___

1. Gillman PK. Neuroleptic malignant syndrome: mechanisms, interactions, and causality. Mov Disord. 2010;25:1780-90.
2. Anglin RE, Rosebush PI, Mazurek MF. Neuroleptic malignant syndrome: a neuroimmunologic hypothesis. CMAJ. 2010;182:834- 8.
3. Uguz F, Sonmez EÖ. Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report. Gen Hosp Psychiatry. 2013;35:327.
4. Lenhard T, Külkens S, Schwab S. Cerebral salt-wasting syndrome in a patient with neuroleptic malignant syndrome. Arch Neurol. 2007;64:122-5.
5. Letmaier M, Painold A, Holl AK, etal: Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. Int J Neuropsychopharmacol. 2012;15:739-48.
6. Kirby D, Harrigan S, Ames D: Hyponatraemia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry. 2002;17:231-7.
7. Ellinas PA, Rosner F, Jaume JC. Symptomatic hyponatremia associated with psychosis, medications, and smoking. J Natl Med Assoc. 1993;85:135-41.
8. Trollor JN, Chen X, Chitty K, Sachdev PS. Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics. Br J Psychiatry. 2012;201:52-6.
9. Wright SK, Schroeter S. Hyponatremia as a complication of selective serotonin reuptake inhibitors. J Am Acad Nurse Pract. 2008;20:47-51.
10. Roxanas M, Hibbert E, Field M. Venlafaxine hyponatraemia: incidence, mechanism and management. Aust N Z J Psychiatry. 2007;41:411-8.